Matuszewski Jason
Matuszewski Jason, CEO, reported a transaction classified as exercise at BioStem Technologies, Inc. involving 8469.000000 shares for an estimated $0.00. Reported holdings after the transaction were 33874.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 15, 2026
- Filing date
- Sep 17, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BSEM price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-394398 Restricted Stock Units
- Transaction date
- Sep 15, 2026 Filed Sep 17, 2026, 08:30 PM · 2d delay
- Shares
- 8,469 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 33,874 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
These options are fully vested and exercisable.
- F2
These options vest according to the following schedule: 33% vested on March 17, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments ove…
- F3
These options vest according to the following schedule: 33%% will vest on October 13, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installmen…
- F4
These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installmen…
- F5
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F6
These restricted stock units vest quarterly over three years from the grant date (September 15, 2024).
- F7
These restricted stock units vest according to the following schedule: 33% vested on March 17, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly in…
- F8
These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarter…
0 other transactions
0 recent txs